Case Scenario Amelia, CEO and founder of BioGenX, arrives at the New York Hilton for an academic conference. Amelia has been travelling for more than 10 hours from her home town of Dresden in Germany. She is tired but her passion and drive is carrying her along. Amelia can’t contain her excitement. The conference brings together esteemed scientists and researchers in the field of genetic medicine, providing an ideal platform for BioGenX to showcase their ground-breaking discoveries and establish collaborations that will Amelia hopes will propel BioGenX on to the world stage. BioGenX's cutting-edge technology revolves around a revolutionary gene-editing algorithm, their most valuable intellectual property. This algorithm holds immense potential for treating genetic diseases and has garnered significant attention within parts of the industry. Additionally, BioGenX possesses sensitive research data, including genetic sequences and clinical trial results, which contribute to their competitive advantage. Anxious to settle in and review her notifications, Amelia finds a local desk in the hotel's designated conference area. The area is quite busy as the conference organizing team is setting up tables and chairs and delegates are milling around shaking hands and making introductions. She glances towards the main entry of the hotel where a limousine has pulled up. She recognizes one of the men stepping out of the car – it’s Pierre, the CEO of GenoDynamics, a large French firm that has been hitting the headlines with its own genetic engineering discoveries. Amelia realizes she is getting distracted. The cameras snapping away in the background aren’t helping. She opens up her laptop and a window pops up on the screen, prompting her to join the hotel's Wi-Fi network. Despite her better judgment, Amelia succumbs to the convenience and accepts the offer, hoping to limit her time online to do a quick check in case there were urgent messages. Amelia logs in to BioGenX’s VPN. She starts up her internal messaging platfom where an email marked ‘priority’ sits at the top of her queue. The email header says “Latest tweaks to the firm’s gene-editing algorithm”. Amelia opens up her email and begins to review the new algorithm. Just then a sudden wave of nausea strikes her. She knows she is going to throw up any second. Overwhelmed by the discomfort, she instinctively rushes off to the washroom, leaving all her belongings behind in her haste. In the washroom, Amelia focuses on alleviating her discomfort. What was that about? She might have eaten something that didn’t set well with her stomach. She was feeling much better after throwing up. Amelia rushes back to the conference area, heart pounding with worry. To her immense relief, Amelia finds her handbag with her credit cards, identification documents and passports, and her laptop were still sitting on the table where she left it. The first panel discussion has already started. The topic is “Revolutionizing Gene Editing: A Glimpse into the Future”. Amelia is excited to be one of the panellists. A key topic being discussed is the effectiveness of various gene editing techniques. After the panel discussion, one of the panellists, Lisa, approaches Amelia. She is very impressed by Amelia’s arguments in favour of using RNA to target specific DNA sequences. Lisa confessed that she had been thinking of the same approach for some time but hadn’t been able to make it work. Amelia was so excited to get some attention! The two sat in a corner by themselves while Amelia explained how she overcame the key hurdles in getting RNA to make precise DNA modifications. Part 1: Risk Register Requirement #1: Identify at least three to five risks. Prioritize these according to criticality. Carefully word the description of each risk to reference an asset, threat actor or threat, potential outcome or impact to the firm and sufficient context to understand the situation and/or differentiate with other scenarios. Requirement #2: Estimate probability of each risk using qualitative ratings (e.g., low, medium, high). Document your level of confidence with each estimation (low, medium, high). Make reasonable assumptions using common sense and logic in your estimations of probability and confidence. Please document these in your written justification (part 2). Requirement #3: Estimate impact of each risk using qualitative ratings (e.g., low, medium, high). Consider the different categories of impact that such a risk can have on the organization. Document your level of confidence with each estimation (low, medium, high). Make reasonable assumptions using common sense and logic in your estimations of impact and confidence. Please document these in your written justification (part 2). Note: Please present the risk register in a table format
Question
Case Scenario
Amelia, CEO and founder of BioGenX, arrives at the New York Hilton for an academic conference. Amelia has been travelling for more than 10 hours from her home town of Dresden in Germany. She is tired but her passion and drive is carrying her along. Amelia can’t contain her excitement. The conference brings together esteemed scientists and researchers in the field of genetic medicine, providing an ideal platform for BioGenX to showcase their ground-breaking discoveries and establish collaborations that will Amelia hopes will propel BioGenX on to the world stage.
BioGenX's cutting-edge technology revolves around a revolutionary gene-editing algorithm, their most valuable intellectual property. This algorithm holds immense potential for treating genetic diseases and has garnered significant attention within parts of the industry. Additionally, BioGenX possesses sensitive research data, including genetic sequences and clinical trial results, which contribute to their competitive advantage.
Anxious to settle in and review her notifications, Amelia finds a local desk in the hotel's designated conference area. The area is quite busy as the conference organizing team is setting up tables and chairs and delegates are milling around shaking hands and making introductions. She glances towards the main entry of the hotel where a limousine has pulled up. She recognizes one of the men stepping out of the car – it’s Pierre, the CEO of GenoDynamics, a large French firm that has been hitting the headlines with its own genetic engineering discoveries.
Amelia realizes she is getting distracted. The cameras snapping away in the background aren’t helping. She opens up her laptop and a window pops up on the screen, prompting her to join the hotel's Wi-Fi network. Despite her better judgment, Amelia succumbs to the convenience and accepts the offer, hoping to limit her time online to do a quick check in case there were urgent messages.
Amelia logs in to BioGenX’s VPN. She starts up her internal messaging platfom where an email marked ‘priority’ sits at the top of her queue. The email header says “Latest tweaks to the firm’s gene-editing algorithm”. Amelia opens up her email and begins to review the new algorithm. Just then a sudden wave of nausea strikes her. She knows she is going to throw up any second. Overwhelmed by the discomfort, she instinctively rushes off to the washroom, leaving all her belongings behind in her haste.
In the washroom, Amelia focuses on alleviating her discomfort. What was that about? She might have eaten something that didn’t set well with her stomach. She was feeling much better after throwing up. Amelia rushes back to the conference area, heart pounding with worry. To her immense relief, Amelia finds her handbag with her credit cards, identification documents and passports, and her laptop were still sitting on the table where she left it.
The first panel discussion has already started. The topic is “Revolutionizing Gene Editing: A Glimpse into the Future”. Amelia is excited to be one of the panellists. A key topic being discussed is the effectiveness of various gene editing techniques. After the panel discussion, one of the panellists, Lisa, approaches Amelia. She is very impressed by Amelia’s arguments in favour of using RNA to target specific DNA sequences. Lisa confessed that she had been thinking of the same approach for some time but hadn’t been able to make it work. Amelia was so excited to get some attention! The two sat in a corner by themselves while Amelia explained how she overcame the key hurdles in getting RNA to make precise DNA modifications. Part 1: Risk Register
Requirement #1: Identify at least three to five risks. Prioritize these according to criticality. Carefully word the description of each risk to reference an asset, threat actor or threat, potential outcome or impact to the firm and sufficient context to understand the situation and/or differentiate with other scenarios.
Requirement #2: Estimate probability of each risk using qualitative ratings (e.g., low, medium, high). Document your level of confidence with each estimation (low, medium, high). Make reasonable assumptions using common sense and logic in your estimations of probability and confidence. Please document these in your written justification (part 2).
Requirement #3: Estimate impact of each risk using qualitative ratings (e.g., low, medium, high). Consider the different categories of impact that such a risk can have on the organization. Document your level of confidence with each estimation (low, medium, high). Make reasonable assumptions using common sense and logic in your estimations of impact and confidence. Please document these in your written justification (part 2).
Note: Please present the risk register in a table format
Solution
Risk Register:
| Risk ID | Risk Description | Probability | Confidence in Probability Estimation | Impact | Confidence in Impact Estimation |
|---|---|---|---|---|---|
| 1 | Unauthorized access to Amelia's laptop containing sensitive data (asset) by potential threat actors present at the conference (threat) leading to data breach and loss of competitive advantage (outcome). | High | High | High | High |
| 2 | Amelia's use of public Wi-Fi (threat) could lead to interception of data transmission by cybercriminals (threat actor), potentially compromising BioGenX's intellectual property (asset). | Medium | High | High | High |
| 3 | Amelia's open discussion of BioGenX's proprietary techniques (asset) with Lisa could lead to potential misuse or replication by competitors (threat), impacting BioGenX's unique market position (outcome). | Medium | Medium | High | Medium |
| 4 | Amelia's physical health issues (threat) could lead to her inability to effectively represent BioGenX at the conference, potentially impacting the company's reputation and business opportunities (outcome). | Low | High | Medium | Medium |
| 5 | The presence of GenoDynamics' CEO Pierre (threat actor) at the conference could lead to potential corporate espionage, impacting BioGenX's competitive advantage (outcome). | Low | Medium | High | Low |
Note: The risks are prioritized based on a combination of their probability and impact, with Risk 1 being the most critical and Risk 5 being the least critical.
Similar Questions
Amelia, CEO and founder of BioGenX, arrives at the New York Hilton for an academic conference. Amelia has been travelling for more than 10 hours from her home town of Dresden in Germany. She is tired but her passion and drive is carrying her along. Amelia can’t contain her excitement. The conference brings together esteemed scientists and researchers in the field of genetic medicine, providing an ideal platform for BioGenX to showcase their ground-breaking discoveries and establish collaborations that will Amelia hopes will propel BioGenX on to the world stage.BioGenX's cutting-edge technology revolves around a revolutionary gene-editing algorithm, their most valuable intellectual property. This algorithm holds immense potential for treating genetic diseases and has garnered significant attention within parts of the industry. Additionally, BioGenX possesses sensitive research data, including genetic sequences and clinical trial results, which contribute to their competitive advantage.Anxious to settle in and review her notifications, Amelia finds a local desk in the hotel's designated conference area. The area is quite busy as the conference organizing team is setting up tables and chairs and delegates are milling around shaking hands and making introductions. She glances towards the main entry of the hotel where a limousine has pulled up. She recognizes one of the men stepping out of the car – it’s Pierre, the CEO of GenoDynamics, a large French firm that has been hitting the headlines with its own genetic engineering discoveries.Amelia realizes she is getting distracted. The cameras snapping away in the background aren’t helping. She opens up her laptop and a window pops up on the screen, prompting her to join the hotel's Wi-Fi network. Despite her better judgment, Amelia succumbs to the convenience and accepts the offer, hoping to limit her time online to do a quick check in case there were urgent messages. Amelia logs in to BioGenX’s VPN. She starts up her internal messaging platfom where an email marked ‘priority’ sits at the top of her queue. The email header says “Latest tweaks to the firm’s gene-editing algorithm”. Amelia opens up her email and begins to review the new algorithm. Just then a sudden wave of nausea strikes her. She knows she is going to throw up any second. Overwhelmed by the discomfort, she instinctively rushes off to the washroom, leaving all her belongings behind in her haste.In the washroom, Amelia focuses on alleviating her discomfort. What was that about? She might have eaten something that didn’t set well with her stomach. She was feeling much better after throwing up. Amelia rushes back to the conference area, heart pounding with worry. To her immense relief, Amelia finds her handbag with her credit cards, identification documents and passports, and her laptop were still sitting on the table where she left it.The first panel discussion has already started. The topic is “Revolutionizing Gene Editing: A Glimpse into the Future”. Amelia is excited to be one of the panellists. A key topic being discussed is the effectiveness of various gene editing techniques. After the panel discussion, one of the panellists, Lisa, approaches Amelia. She is very impressed by Amelia’s arguments in favour of using RNA to target specific DNA sequences. Lisa confessed that she had been thinking of the same approach for some time but hadn’t been able to make it work. Amelia was so excited to get some attention! The two sat in a corner by themselves while Amelia explained how she overcame the key hurdles in getting RNA to make precise DNA modifications.
Jessica believes that sequencing the DNA of the murderer’s children would be unethical and intrusive. How might a virtues-based approach to bioethics support this conclusion?
Title: Navigating the Ethical Terrain of Human Genetic Engineering: Balancing Possibilities, Risks and Equities Introduction A brief overview of genetic engineering and its potential in humans Introduction to CRISPR-Cas9 and its significance A preview of the ethical considerations and social implications to be discussed. II Understanding the potential benefits Exploring potential medical breakthroughs through genetic engineering Examples of diseases that can potentially be treated or prevented. Addition of desirable traits and the concept of genetic enhancement Discuss how genetic engineering can contribute to advances in personalized medicine III Assessing Risks and Ethical Concerns Examination of potential risks associated with genetic engineering, including unintended mutations and off-target effects Ethical concerns related to germ cell modification and implications for future generations Consider the potential for abuse, including eugenics and designer babies Discussion of concerns regarding consent, autonomy, and potential for discrimination IV Navigating Ethical Dilemmas Exploring ethical frameworks for evaluating human genetic engineering, including utilitarianism, deontology, and ethics Discuss the importance of public engagement and dialogue in the formulation of ethical guidelines and policies Consideration of regulatory frameworks and international cooperation in managing ethical dilemmas An examination of the role of health care professionals, scientists, policy makers, and ethicists in addressing ethical challenges. V. To ensure equity and guard against unintended consequences Discuss the importance of equitable access to genetic technologies and health care services Consideration of socio-economic disparities and the potential for widening existing inequalities Exploring strategies to ensure transparency, accountability, and oversight in genetic research and applications Evaluation of the role of education and public awareness in promoting the responsible use of genetic technologies VI CONCLUSION Summary of key points discussed regarding the ethical implications of human genetic engineering A call for continued interdisciplinary collaboration and ethical reflection in the development and application of genetic technologies Emphasis on the importance of balancing the potential benefits of genetic engineering with ethical considerations and societal values This outline provides a systematic approach to addressing the overarching question you pose, allowing for an in-depth exploration of the ethical implications of genetic engineering in humans. short Introduction fairy II Potential benefits of genetic engineering in humans Former Discs Exam A III Risks and Ethical Concerns identity Ethical Discussion of IV Navigating Ethical Dilemmas Exploration a Examination Ampo V. Ensuring Equitable Access and Protecting Against Unintended Consequences Discussion of th Examination Street VI CONCLUSION Again Emphasizes the need for a ba
What research topics might Bacillus species be good model organisms for?Group of answer choicesBacterial cell divisionDNA replicationOrgan developmentGene regulationHistone modificationintron splicingCRISPR
How has the Human Microbiome Project impacted medical research?Group of answer choicesIt has led to a better understanding of the human immune system and its interactions with microbesIt has led to the development of new antibioticsIt has revealed the importance of the human microbiome in health and diseaseIt has helped to identify new drug targets for treating human diseases
Upgrade your grade with Knowee
Get personalized homework help. Review tough concepts in more detail, or go deeper into your topic by exploring other relevant questions.